Spruce Biosciences Inc (SPRB)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$46.61+8.88%
Close 2026-11-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · SPRB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | 4.9 | 10.1 | 0.0 | — | — |
| Total Revenues | — | — | 4.9 | 10.1 | 0.0 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 28.9 | 19.5 | 46.4 | 49.4 | 35.2 | 30.7 | 23.9 |
| Operating Income | (47.8) | (36.5) | (56.2) | (52.0) | (47.3) | (42.1) | (29.4) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | 1.8 | 0.1 | 0.3 | 0.5 | 0.4 | 0.3 | 0.3 |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (51.4) | (39.0) | (53.0) | (47.9) | (46.2) | (42.3) | (29.5) |
| Per Share | |||||||
| Basic EPS | (21.12) | (50.83) | (1.29) | (1.24) | (1.96) | (1.81) | — |
| Diluted EPS | (21.12) | (50.83) | (1.29) | (1.24) | (1.96) | (1.81) | — |
| Basic Weighted Avg Shares | 2.4 | 0.8 | 41.3 | 38.5 | 23.5 | 23.4 | — |
| Diluted Weighted Avg Shares | 2.4 | 0.8 | 41.3 | 38.5 | 23.5 | 23.4 | — |
| Supplemental | |||||||
| EBITDA | — | (36.5) | (56.1) | (51.9) | (47.2) | (42.0) | (29.4) |
| EBIT | (47.8) | (36.5) | (56.2) | (52.0) | (47.3) | (42.1) | (29.4) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.